Tibial neurostimulation system demonstrates safety and efficacy in urge urinary incontinence
April 30th 2023“We looked at safety issues within 12 months after the implantation, and they were minor—some pain problems, some wound-healing problems, but no serious adverse events,” said John Heesakkers, MD, PhD.
Hypertension predicts worse outcomes for patients undergoing nephroureterectomy for UTUC
April 30th 2023“What we found is that hypertension is an independent risk factor for worsened survival outcomes and mortality outcomes across the board on multivariable and Kaplan Meier analysis,” said Sohail Dhanji, MD.
Dr. Hafron discusses the use of oral Relugolix in prostate cancer
April 29th 2023"What we noticed is that even though it's not in the NCCN guidelines, a lot of urologists are using oral Relugolix in combination with other prostate cancer medications in similar numbers to the injectables," says Jason M. Hafron, MD.
Dr. Sun discusses gender-affirming care among transgender and gender diverse youth
April 29th 2023"Something that we did find that was more promising was that regardless of whether a patient did or did not have a mental health disorder diagnosis, that did not affect their rate of receiving gender-affirming medical therapy," says Helen Sun, MD.
Functional outcomes are equivalent after HoLEP regardless of receipt of prior BPH procedure
April 28th 2023"Patients with a prior BPH procedure were on average older than our HoLEP controls; however, there were no other differences in preoperative patient characteristics or postoperative functional outcomes," said Nicholas S. Dean, MD.
Zoledronic Acid reduces clinically significant fractures in mHSPC
April 28th 2023A database analysis of patients who participated in the STAMPEDE trial showed that zoledronic acid can significantly lower the risk of fracture in patients with with metastatic hormone-sensitive prostate cancer starting long-term ADT.
Results of phase 3 PADRES trial of neoadjuvant axitinib in renal cell carcinoma
May 20th 2022In the PADRES trial, neoadjuvant axitinib facilitated partial nephrectomy in patients with clear cell renal cell carcinoma and complex masses with an imperative indication for nephron-sparing surgery but no viable pathway to receive the procedure.
Elevated FSH is associated with decline in sperm concentration
May 20th 2022“We found that men with an elevated FSH but a normal semen test were more likely to have a decline in their sperm concentration and their total motile sperm count over time…when compared to men also starting with the normal semen test but with a normal FSH,” says Joshua Halpern, MD.